E-LIB Suche - Ergebnisse für: Fonseca Casals, M.F.

1

Presence and evolution of a new psychoactive tryptamines br..:

Palma Conesa, Á. ; Galindo Guarin, L. ; Grifell Guardia, M....
European Psychiatry. 33 (2016) S1 - p. S117-S118 , 2016

2

P.6.c.009 Benzodiazepine dependence disorder in a detoxific..:

Espluga Frigola, N. ; Malagon Amor, M.A. ; Fonseca Casals, M.F....
European Neuropsychopharmacology. 16 (2006) - p. S505 , 2006

Link: https://doi.org/10.1016/..

3

Temporal trends of drug requests in the Addiction Liaison P..:

García Jimenez, M. ; Fuentes Valenzuela, J. J. ; Fonseca Casals, F. F. C..
European Psychiatry. 66 (2023) S1 - p. S667-S667 , 2023

Link: https://doi.org/10.1192/..

4

Lamotrigine use and risk of prescription – review of a one ..:

Garcia-Fuentes, D. ; Carrió-Díez, E. ; Codina, G.A. Mateu...
Neuroscience Applied. 1 (2022) - p. 100937 , 2022

Link: https://doi.org/10.1016/..

5

Not only alcohol – the relation between folate deficiency a..:

Martínez, E. Pechuán ; Cáceres, F. Dinamarca ; Jiménez, M. Garcia...
Neuroscience Applied. 1 (2022) - p. 100710 , 2022

Link: https://doi.org/10.1016/..

6

P.6.e.006 Drug users and antipsychotics: the role of off-la..:

Rossi, P. ; Subero, M. Martín ; Delgar, B. García...
European Neuropsychopharmacology. 21 (2011) - p. S596-S597 , 2011

Link: https://doi.org/10.1016/..

7

P.873Personality disorders and substance misuse comorbidity..:

Mateu-Codina, G. ; Alayón-Santana, R. ; Sauras-Quetcuti, R.B....
European Neuropsychopharmacology. 40 (2020) - p. S485-S486 , 2020

Link: https://doi.org/10.1016/..

8

P.874FAAH polimorphisms as a promising genetic markers in s..:

Mateu-Codina, G. ; Sauras-Quetcuti, R.B. ; Farre-Martinez, A....
European Neuropsychopharmacology. 40 (2020) - p. S486-S487 , 2020

Link: https://doi.org/10.1016/..

9

Subjects affected by a substance use disorder with or witho..:

Mateu-Codina, G. ; Fonseca-Casals, F. ; Gratacos-Mayora, M....
European Neuropsychopharmacology. 29 (2019) - p. S174-S175 , 2019

Link: https://doi.org/10.1016/..

10

Temporal trends of drug requests in the Addiction Liaison P..:

M. García Jimenez ; J. J. Fuentes Valenzuela ; F. F. C. Fonseca Casals.
https://www.cambridge.org/core/product/identifier/S0924933823013895/type/journal_article. , 2023

Link: https://doi.org/10.1192/..

11

Subject characteristics of medical requests to the Addictio..:

J. J. Fuentes Valenzuela ; M. García Jimenez ; F. Fonseca Casals.
https://www.cambridge.org/core/product/identifier/S0924933823013809/type/journal_article. , 2023

Link: https://doi.org/10.1192/..

12

Systemic involvement in primary Sjogren's syndrome evaluate..:

Ramos-Casals, M. ; Brito-Zeron, P. ; Solans, R....
Rheumatology. 53 (2013) 2 - p. 321-331 , 2013

Link: https://doi.org/10.1093/..

13

CANreduce-SP-adding psychological support to web-based adhe..:

Mestre-Pintó, Juan Ignacio ; Fonseca Casals, Francina, 1972- ; Schaub, M. P...
Mestre-Pintó JI, Fonseca F, Schaub MP, Baumgartner C, Alias-Ferri M, Torrens M. et al. CANreduce-SP-adding psychological support to web-based adherence-focused guided self-help for cannabis users: study protocol for a three-arm randomized control trial. Trials. 2022 Jun 22; 23(1): 524. DOI:10.1186/s13063-022-06399-2. ,

Link: http://hdl.handle.net/10..

14

Characterization and outcomes of 414 patients with primary ..:

Hern('a)ndez-Molina, G ; Kostov, B ; Brito-Zer('o)n, P...
info:eu-repo/semantics/altIdentifier/pmid/35385104. , 2023

Link: https://hdl.handle.net/1..

15

Coexistence of immune-mediated diseases in sarcoidosis. Fre..:

Brito-Zerón, Pilar ; Pérez-Alvarez, Roberto ; Feijoo-Massó, Carles...
Joint Bone Spine. 88 (2021) 6 - p. 105236 , 2021

Link: https://doi.org/10.1016/..